TraderTV Live was happy to welcome Tim Moore, CEO of HAVN Life Sciences, HAVN Life Sciences is an industry leader in biotechnology, aimed to improve cognitive performance through the psychoactive compounds. HAVN is working on two important fronts that each offer unique opportunities for investors looking to take advantage of this fast-moving market. First, through its HAVN Labs division, the company is devoted to providing standardized psychedelic compound formulations for academic researchers and formulators and second, through its HAVN Retail division, the company is developing and bringing to market custom formulations both directly to the consumer as well as with contract manufacturing)! ********* Watch our Live Trading show, Monday to Friday from 8:30 am to 11:30am! https://www.youtube.com/tradertvlive
Legal Notice: The views and opinions expressed on TraderTV.Live are provided for information purposes only and should NOT be taken as (a) a solicitation of an offer to buy or sell a security, (b) an endorsement or recommendation of any particular security or trading strategy, or (c) investment advice.
The trading activity shown on TraderTV.Live are stocks, futures and Forex purchases and sales, using real money and real-time market data. Our traders may own the securities they are trading on TraderTV.Live in their personal portfolios.
BEFORE MAKING ANY INVESTMENT DECISION, IT IS STRONGLY RECOMMENDED YOU SEEK ADVICE FROM A QUALIFIED BROKER OR INVESTMENT ADVISOR.
TRADERTV.LIVE DOES NOT PROVIDE OR GUARANTEE ANY FINANCIAL, LEGAL, TAX, OR ACCOUNTING ADVICE OR ADVICE REGARDING THE SUITABILITY, PROFITABILITY, OR POTENTIAL VALUE OF ANY PARTICULAR SECURITY, TRADING STRATEGY, OR INFORMATION SOURCE.
This segment of TraderTV.Live features an interview of a representative of a company publicly traded in the United States (the “Profiled Issuer”) discussing the company, its business, and/or its prospects (the “Information”). TraderTV.Live has not reviewed or vetted, and does not make any comment on or otherwise endorse, the accuracy, relevance, or completeness of the Information. Since we have been paid to disseminate the Information to the public pertaining to securities of the Profiled Issuer, we are required by Section 17(b) of the Securities Act of 1933, as amended, to specifically disclose our compensation. TraderTV.Live received payment of 3000 Canadian dollars from the Profiled Issuer’s media representative as consideration for the Profiled Issuer’s representative being interviewed on the show.